Evidence-Based Medicine Guidelines
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sulphonylurea Monotherapy for Patients With Type 2 Diabetes Mellitus." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458223/all/Sulphonylurea_monotherapy_for_patients_with_type_2_diabetes_mellitus.
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458223/all/Sulphonylurea_monotherapy_for_patients_with_type_2_diabetes_mellitus. Accessed December 6, 2023.
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458223/all/Sulphonylurea_monotherapy_for_patients_with_type_2_diabetes_mellitus
Sulphonylurea Monotherapy for Patients With Type 2 Diabetes Mellitus [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458223/all/Sulphonylurea_monotherapy_for_patients_with_type_2_diabetes_mellitus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
ID - 458223
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458223/all/Sulphonylurea_monotherapy_for_patients_with_type_2_diabetes_mellitus
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
